Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
2.
Urologe A ; 60(1): 8-18, 2021 Jan.
Article in German | MEDLINE | ID: mdl-33301070

ABSTRACT

White light cystoscopy and the concise documentation of pathological findings are standard diagnostic procedures in urology. Additional imaging modalities and technical innovations may support clinicians in the detection of bladder tumors. Modern endoscopy systems provide ultra-high-resolution imaging and the option of digital contrast enhancement. Photodynamic diagnostics and narrow band imaging are well-established in clinical routine and have shown significant benefits in the detection of bladder cancer. By means of multispectral imaging, different modalities can now be combined in real-time. Probe-based procedures such as optical coherence tomography (OCT) or Raman spectroscopy can further contribute to advanced imaging through an "optical biopsy" which may primarily improve diagnostics in the upper urinary tract. The aim of all techniques is to optimize the detection rate in order to achieve a more accurate diagnosis, resection and lower recurrence rates. Current research projects aim to digitalize the documentation of endoscopy and also make it more patient- and user-friendly. In the future, the use of image processing and artificial intelligence may automatically support the surgeon during endoscopy.


Subject(s)
Artificial Intelligence , Urinary Bladder Neoplasms , Cystoscopy , Humans , Narrow Band Imaging , Neoplasm Recurrence, Local , Urinary Bladder Neoplasms/diagnostic imaging
3.
Appl Opt ; 55(15): 4261-9, 2016 May 20.
Article in English | MEDLINE | ID: mdl-27411158

ABSTRACT

We present a novel bimodal endoscopic imaging probe that can simultaneously provide full-field white-light video microscopy and confocal optical coherence tomography (OCT) depth scans. The two modalities rely on spectrally separated optical paths that run partially in parallel through a micro-optical bench system, which has a cross-section of only 2 mm×2.76 mm and is realized via standard silicon micromachining techniques. With a numerical aperture of 0.061, the video modality has a resolution and field of view of 9.3 and 1240 µm×1080 µm, respectively. The resolution is limited by the pixel spacing of the coherent fiber bundle, which relays the acquired image from the distal to the proximal end. A custom-designed diffractive optical element placed within the video imaging path significantly improves the image contrast by up to 45% in the medium frequency range. The OCT modality is optimized for 830 nm center wavelength, and works in a confocal arrangement with an NA of 0.018. It provides single-point depth probing at the center of the video image with a lateral resolution of 20 µm. Through its compact footprint and enhanced functionality, the probe can provide depth-resolved guiding capability for existing laparoscopes and represents a major step toward a new class of multimodal endoscopic imaging probes.

4.
Appl Opt ; 55(10): 2718-23, 2016 04 01.
Article in English | MEDLINE | ID: mdl-27139677

ABSTRACT

A key feature of Alvarez lenses is that they may be tuned in focal length using lateral rather than axial translation, thus reducing the overall length of a focus-tunable optical system. Nevertheless the bulk of classical microsystems actuators limits further miniaturization. We present here a new, ultrathin focus-tunable Alvarez lens fabricated using molding techniques and actuated using liquid crystal elastomer (LCE) artificial muscle actuators. The large deformation generated by the LCE actuators permits the integration of the actuators in-plane with the mechanical and optical system and thus reduces the device thickness to only 1.6 mm. Movement of the Alvarez lens pair of 178 µm results in a focal length change of 3.3 mm, based on an initial focal length of 28.4 mm. This design is of considerable interest for realization of ultraflat focus-tunable and zoom systems.


Subject(s)
Computer-Aided Design , Lens, Crystalline , Miniaturization , Equipment Design , Lenses , Muscles
5.
Opt Express ; 23(19): 24525-36, 2015 Sep 21.
Article in English | MEDLINE | ID: mdl-26406656

ABSTRACT

We describe a novel approach for fabricating customized convex as well as concave micro-lenses using substrates with sophisticated pinning architecture and utilizing a drop-on-demand jet printer. The polymeric lens material deposited on the wafer is cured by UV light irradiation yielding lenses with high quality surfaces. Surface shape and roughness of the cured polymer lenses are characterized by white light interferometry. Their optical quality is demonstrated by imaging an USAF1951 test chart. The evaluated modulation transfer function is compared to Zemax simulations as a benchmark for the fabricated lenses.

6.
Adv Drug Deliv Rev ; 60(1): 79-87, 2008 Jan 03.
Article in English | MEDLINE | ID: mdl-17884238

ABSTRACT

Cyanovirin-N (CV-N) is a potent inhibitor of human immunodeficiency virus and many other viruses. It has a high potential for use as a systemic compound to control viral load or in the development of microbicides to prevent primary viral infection. Due to its cyanobacterial origin it is likely to show the typical drawbacks associated with pharmaceutical use of foreign proteins such as short plasma half-life, proteolysis and immunogenicity. Several strategies were used to covalently bond poly(ethylene glycol) (PEGylate) to CV-N. Random PEGylation at lysine residues resulted in poor retention of antiviral activity. Many site-directed mutants were made to test site-specific PEGylation. One mutant, where glutamine 62 was replaced with cysteine (CV-N(Q62C)) and PEGylated with maleimide activated PEG, retained significant anti-HIV activity in vitro.


Subject(s)
Anti-HIV Agents/chemistry , Bacterial Proteins/chemistry , Carrier Proteins/chemistry , HIV Infections/prevention & control , Polyethylene Glycols/chemistry , Amino Acid Sequence , Anti-HIV Agents/therapeutic use , Bacterial Proteins/therapeutic use , Carrier Proteins/therapeutic use , Drug Compounding/methods , Humans , Molecular Sequence Data , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
8.
Lett Appl Microbiol ; 42(6): 600-5, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16706899

ABSTRACT

AIM: DNA fingerprinting using (GTG)(5) oligonucleotide as a primer in a random amplified polymorphic DNA (RAPD) assay was assessed by typing isolates of Campylobacter concisus strains, collected over a period of 8 years. METHODS AND RESULTS: RAPD analysis using the (GTG)(5) oligonucleotide as a primer was used to type 100 isolates of C. concisus comprising mostly isolates from children with diarrhoea. Using this method, 86% of the isolates were found to be genotypically diverse. Of these heterogeneous isolates, 25 of the strains were also shown to be genetically distinct in a previous study using pulsed field gel electrophoresis. The remaining isolates (14) could be classified into five profile groups based on the DNA fingerprinting patterns. The assay successfully identified epidemiologically linked strains from the unrelated genetically diverse pool of strains. CONCLUSIONS: Laboratory RADP typing using the (GTG)(5) primer proved to be useful in distinguishing related strains of C. concisus from a large pool of unrelated strains of this organism. SIGNIFICANCE AND IMPACT OF THE STUDY: RAPD typing using (GTG)(5) is a simple method that could be used to investigate the epidemiology of C. concisus. The results suggest that homologous lineages of C. concisus may exist within an otherwise heterogeneous species complex. However, these data need to be confirmed using a more robust typing method.


Subject(s)
Bacterial Typing Techniques/methods , Campylobacter/classification , DNA Primers , Oligonucleotides/genetics , Random Amplified Polymorphic DNA Technique/methods , Adult , Campylobacter/genetics , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Child , DNA Fingerprinting/methods , Electrophoresis, Gel, Pulsed-Field , Humans
9.
Vet Rec ; 152(26): 804-6, 2003 Jun 28.
Article in English | MEDLINE | ID: mdl-12862169

ABSTRACT

Five horses with moderate to severe chronic obstructive pulmonary disease (COPD) were treated with 0.11 (0.01) mg/kg bodyweight of montelukast, a cysteinyl leukotriene receptor antagonist, once a day for 26 days. The horses were evaluated clinically and endoscopically and subjected to arterial blood gas analysis and lung function tests before and after the period of treatment, and the plasma concentrations of montelukast were determined by high-performance liquid chromatography with fluorescence detection. The treatment did not result in statistically significant differences in the total scores of clinical and endoscopical signs, or in the difference in the arterioalveolar partial pressure of oxygen, maximal changes in pleural pressure, pulmonary resistance or dynamic compliance. The mean (sd) peak plasma concentration (C(max0) of montelukast was 12 (4) ng/ml and was reached 66 (13) minutes (t(max)) after its oral administration. The dose of montelukast per kg bodyweight was approximately the same as that for human beings, but the C(max) in the horses was 28 times lower and the t(max) was reached in one-fifth of the time, suggesting that its oral bioavailability may be lower.


Subject(s)
Acetates/therapeutic use , Horse Diseases/drug therapy , Leukotriene Antagonists/therapeutic use , Pulmonary Disease, Chronic Obstructive/veterinary , Quinolines/therapeutic use , Animals , Cyclopropanes , Female , Horses , Male , Pulmonary Disease, Chronic Obstructive/classification , Pulmonary Disease, Chronic Obstructive/drug therapy , Respiration/drug effects , Severity of Illness Index , Sulfides , Treatment Outcome
10.
Vet Rec ; 152(18): 555-7, 2003 May 03.
Article in English | MEDLINE | ID: mdl-12751606

ABSTRACT

The effects of an oral preparation containing an extract of thyme and primula (Bronchipret; Bionorica) on the lung function of five horses suffering heaves were determined in a longitudinal study. The horses accepted the product well. The plasma concentrations of the marker substance, thymol, indicated that at least one of the substances in the extract had been absorbed from the gastrointestinal tract. The compliance, pulmonary pressure and airway resistance of the horses' lungs were all significantly improved after one month of treatment However, the severity of their clinical signs and their arterial oxygen partial pressure had not improved significantly.


Subject(s)
Airway Obstruction/veterinary , Bronchodilator Agents/therapeutic use , Horse Diseases/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Primula , Thymol/therapeutic use , Thymus Plant , Administration, Oral , Airway Obstruction/drug therapy , Animals , Bronchodilator Agents/administration & dosage , Horse Diseases/blood , Horse Diseases/pathology , Horses , Longitudinal Studies , Pilot Projects , Plant Extracts/administration & dosage , Plant Roots , Recurrence , Respiratory Function Tests/veterinary , Severity of Illness Index , Thymol/administration & dosage , Thymol/blood
11.
Tuberculosis (Edinb) ; 81(4): 279-89, 2001.
Article in English | MEDLINE | ID: mdl-11584596

ABSTRACT

De novo protein synthesis and the heat-shock response during different stages of bacterial culture of Mycobacterium smegmatis LR222 were investigated. A discontinuance in the increase in number of colony forming units occurred at mid-exponential phase of growth. This coincided with a plateau in the ATP content of the culture, a reduction in the synthesis of exponential phase proteins (58, 30.5, and 20 kDa), a transitory synthesis of a 32 kDa protein and the induction of stationary-phase proteins (48, 46, 31, 25, and 20 kDa). The response to heat shock showed a growth-phase dependency, with the highest fold-induction of the 75 kDa (DnaK) protein occurring during the transitory cessation in the increase in CFU, while the greatest increase of the 95 kDa, 66 kDa (GroEL), and approximately 17 kDa (a doublet) proteins occurred during stationary phase. The approximately 17 kDa doublet was resolved into four polypeptides by two-dimensional electrophoresis. Mass spectrometric analysis of the sequence of one polypeptide (named Hsp17-2, 16.8 kDa) revealed significant homology to a conserved, 16.2 kDa, hypothetical protein of unknown function in Mycobacterium tuberculosis H37Rv. The increased synthesis of Hsp17-2 in response to heat shock suggests that it may represent a new low molecular weight heat shock protein.


Subject(s)
Bacterial Proteins/isolation & purification , Heat-Shock Proteins/isolation & purification , Mycobacterium smegmatis/metabolism , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Colony Count, Microbial , Crystallins/biosynthesis , Electrophoresis, Polyacrylamide Gel , Heat-Shock Proteins/chemistry , Heat-Shock Proteins/metabolism , Humans , Molecular Sequence Data , Molecular Weight , Mycobacterium smegmatis/growth & development
12.
Appl Opt ; 39(15): 2475-9, 2000 May 20.
Article in English | MEDLINE | ID: mdl-18345162

ABSTRACT

The use of vertical-cavity surface-emitting lasers (VCSEL's) for optical detection of atmospheric oxygen is described. The VCSEL's were custom designed for single-mode emission in the 763-nm wavelength range, with low noise and narrow optical linewidth. Using standard wavelength modulation spectroscopy and a second-harmonic detection scheme with a 1-m air path, we determined an oxygen concentration resolution of 0.2%. Because of its small size, low power dissipation, and good tunability characteristics, the VCSEL promises to be an attractive light source for use in compact, low-cost optical sensor microsystems for trace gas detection.

13.
Gene ; 240(2): 361-70, 1999 Nov 29.
Article in English | MEDLINE | ID: mdl-10580156

ABSTRACT

Mycobacterium tuberculosis, the causative agent of tuberculosis, may remain dormant within its host for many years. The nature of this dormant or latent state is not known, but it may be a specialized form of the stationary growth phase. In Escherichia coli, KatF (or RpoS) is the major stationary phase sigma factor regulating an array of genes expressed in this phase of growth. A potential M. tuberculosis katF homologue was cloned using a fragment of the E. coli katF gene as a probe. DNA sequence analysis of a resultant clone showed 100% identity to a fragment of DNA encoding the M. tuberculosis mysA and mysB genes. Overexpression of mysB in M. bovis BCG resulted in an increase in katG mRNA and catalase and peroxidase activity, and an increase in sensitivity of the cells to isoniazid. An increase in katG promoter activity from a reporter vector was demonstrated when mysB was overexpressed from the same plasmid, indicating a direct relationship between MysB and katG expression.


Subject(s)
Bacterial Proteins/physiology , Escherichia coli/genetics , Mycobacterium tuberculosis/genetics , Sigma Factor/physiology , Bacterial Proteins/genetics , Blotting, Southern , Catalase/metabolism , DNA Probes , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Drug Resistance, Microbial , Escherichia coli/physiology , Gene Expression Regulation, Bacterial , Isoniazid/pharmacology , Luciferases/genetics , Luciferases/metabolism , Microbial Sensitivity Tests , Mycobacterium bovis/drug effects , Mycobacterium bovis/genetics , Mycobacterium smegmatis/genetics , Mycobacterium tuberculosis/physiology , Peroxidase/metabolism , Peroxidases/genetics , Polymerase Chain Reaction , Promoter Regions, Genetic/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Fusion Proteins/genetics , Sigma Factor/genetics , Single-Strand Specific DNA and RNA Endonucleases/metabolism
14.
Eur J Anaesthesiol ; 16(2): 118-29, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10101629

ABSTRACT

Two daily doses of oral Harpagophytum extract WS 1531 (600 and 1200, respectively, containing 50 and 100 mg of the marker harpagoside) were compared with placebo over 4 weeks in a randomized, double-blind study in 197 patients with chronic susceptibility to back pain and current exacerbations that were producing pain worse than 5 on a 0-10 visual analogue scale. The principal outcome measure, based on pilot studies, was the number of patients who were pain free without the permitted rescue medication (tramadol) for 5 days out of the last week. The treatment and placebo groups were well matched in physical characteristics, in the severity of pain, duration, nature and accompaniments of their pain, the Arhus low back pain index and in laboratory indices of organ system function. A total of 183 patients completed the study. The numbers of pain-free patients were three, six and 10 in the placebo group (P), the Harpagophytum 600 group (H600) and the Harpagophytum 1200 group (H1200) respectively (P = 0.027, one-tailed Cochrane-Armitage test). The majority of responders' were patients who had suffered less than 42 days of pain, and subgroup analyses suggested that the effect was confined to patients with more severe and radiating pain accompanied by neurological deficit. However, subsidiary analyses, concentrating on the current pain component of the Arhus index, painted a slightly different picture, with the benefits seeming, if anything, to be greatest in the H600 group and in patients without more severe pain, radiation or neurological deficit. Patients with more pain tended to use more tramadol, but even severe and unbearable pain would not guarantee that tramadol would be used at all, and certainly not to the maximum permitted dose. There was no evidence for Harpagophytum-related side-effects, except possibly for mild and infrequent gastrointestinal symptoms.


Subject(s)
Glycosides , Low Back Pain/drug therapy , Plant Extracts/therapeutic use , Pyrans/therapeutic use , Analgesics, Opioid/therapeutic use , Chronic Disease , Double-Blind Method , Female , Humans , Low Back Pain/diagnosis , Male , Middle Aged , Pain Measurement , Plant Extracts/adverse effects , Pyrans/adverse effects , Tramadol/therapeutic use
15.
Tuber Lung Dis ; 79(5): 299-308, 1999.
Article in English | MEDLINE | ID: mdl-10707258

ABSTRACT

SETTING: Molecular Research Laboratory, Department of Medical Microbiology, University of Cape Town and Groote Schuur Hospital. OBJECTIVE: Characterize Mycobacterium tuberculosis homologue of the Streptomyces coelicolor, sporulation specific, whiB regulatory gene. DESIGN: The M. tuberculosis whiB3 gene was isolated by enriched cloning of a 2.8 kb BamHl fragment to which the S. coelicolor whiB gene hybridized. Expression of the gene was analysed by S1 nuclease analysis and promoter studies. RESULTS: An open reading frame within the 2.8 kb BamHl fragment was identified as the M. tuberculosis whiB3 gene, one of four whiB homologues in the M. tuberculosis genome. The deduced amino acid sequence has a 92% identity with a M. leprae protein, and 32% identity with the S. coelicolor WhiB protein. S1 nuclease analysis showed that the M. tuberculosis whiB3 gene is constitutively expressed by the cells in liquid culture. Primer extension analysis revealed three transcriptional start sites. Expression from the three potential promoters is growth phase-dependent. CONCLUSION: The M. tuberculosis whiB3 gene is expressed throughout growth, but expression from the individual promoters is growth phase dependent.


Subject(s)
Bacterial Proteins/genetics , Mycobacterium tuberculosis/genetics , Streptomyces/genetics , Transcription Factors/genetics , Bacterial Proteins/chemistry , Blotting, Southern , Humans , Mycobacterium/genetics , Open Reading Frames , Polymerase Chain Reaction , Promoter Regions, Genetic , Protein Structure, Secondary , RNA, Bacterial/genetics , RNA, Messenger/genetics , Transcription Factors/chemistry
16.
Epidemiol Infect ; 121(1): 103-8, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9747761

ABSTRACT

The risk of Borrelia burgdorferi infection and the value of antibiotic prophylaxis after tick bite are controversial. In this study, performed in two areas of southwestern Germany, ticks were collected from 730 patients and examined by the polymerase chain reaction (PCR) for B. burgdorferi. To assess whether transmission of B. burgdorferi occurred, the patients were clinically and serologically examined after tick removal and during follow-up examinations. Data from all tick bites gave a total transmission rate of 2.6% (19 patients). Eighty-four ticks (11.3%) were PCR positive. Transmission occurred to 16 (26.7%) of 60 patients who were initially seronegative and could be followed up after the bite of an infected tick. These results indicate that the transmission rate from infected ticks in Europe is higher than previously assumed. Examination of ticks and antibiotic prophylaxis in the case of positivity appears to be indicated.


Subject(s)
Borrelia burgdorferi Group/isolation & purification , Ixodes/microbiology , Lyme Disease/epidemiology , Adolescent , Adult , Aged , Animals , Antibodies, Bacterial/analysis , Child , Child, Preschool , Female , Germany/epidemiology , Humans , Infant , Lyme Disease/diagnosis , Lyme Disease/transmission , Male , Middle Aged , Polymerase Chain Reaction , Serologic Tests
17.
Eur J Anaesthesiol ; 15(4): 397-408, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9699096

ABSTRACT

A postal survey was carried out on every 71st person aged between 18 and 80 in the population registers in County Regierungsbezirk Karlsruhe in the State of Baden-Würtemberg. It asked 2127 persons whether they had, in the previous 6 months, experienced any form of unduly prolonged pain (as distinct from brief intercurrent self-limiting episodes related to injury inflammation etc.) and, if so, to specify its location, duration, severity and persistence. It also sought information on the resulting calls on healthcare professionals and the degree of satisfaction with treatments received. The age and gender distributions of the sample selected for survey matched those in the population from which it was drawn. Of the 1420 respondents, only 1304 declared their age and gender--a condition for inclusion in the analysis. Of these, 610 reported some form of unduly prolonged pain, which had lasted more than a year in 530. For all pain lasting longer than a year, the estimated prevalence of mild pain was 11%, severe 25% and intolerable 3.5%: the corresponding estimates for persistent as opposed to episodic pain were 2% for mild, 10% for sever and 1% for intolerable. Pain was present in more than one anatomical location in most of those who reported it. Musculoskeletal pain was overwhelmingly the most common. Increasing age, obesity and being female pre-disposed to the reporting of pain, with women being more liable to report headache and pain in the neck and shoulder. One hundred and thirty-six pain reporters either gave no information on consultation or sought no help from healthcare professionals: a third of the remainder consulted more than one professional, with general practitioners and specialists in physical medicine (niedergelassener Orthopäde) being the most common. A wide variety of treatments were used, with oral medications, massage, exercises, mud pack and heat treatment being the most popular; two-thirds of sufferers used more than one type of treatment. The most popular types of treatment tended also to be the most successful, except for oral medication (which was also the most heterogeneous). Multiple logistic regression analyses identified consistent associations between duration and severity of pain, the number of sites where it was reported, the numbers of healthcare professionals consulted and the number of treatments tried, and the same groupings of features were associated with decreased likelihood of overall satisfaction with treatment received.


Subject(s)
Health Services/statistics & numerical data , Pain/epidemiology , Adolescent , Adult , Age Distribution , Age Factors , Aged , Analgesics/administration & dosage , Analgesics/therapeutic use , Bone Diseases/epidemiology , Chronic Disease , Family Practice/statistics & numerical data , Female , Germany/epidemiology , Headache/epidemiology , Humans , Logistic Models , Male , Middle Aged , Muscular Diseases/epidemiology , Neck Pain/epidemiology , Obesity/epidemiology , Orthopedics/statistics & numerical data , Patient Satisfaction , Physical Therapy Modalities , Prevalence , Sex Distribution , Sex Factors , Shoulder/physiopathology
18.
Gene ; 188(1): 123-8, 1997 Mar 25.
Article in English | MEDLINE | ID: mdl-9099870

ABSTRACT

The monoclonal antibody, mAb3C4, raised against sonicated Mycobacterium bovis (Mb) BCG (Tokyo strain 172) cells recognises a 23-kDa protein in the cell wall. The gene encoding this protein was cloned and sequenced and found to be 100% homologous to mpb83 and mpt83 and the putative protein to have a 76% sequence similarity to the secreted, Mb-specific protein, MPB70. MPB83 contains the amino acid (aa) sequence LAGC, which corresponds to the consensus sequence for bacterial lipoprotein modification and processing. MPB83 associated with the detergent phase when separated with Triton X-114 confirming that it is a lipoprotein. When the putative site of acylation, the Cys in the sequence LAGC, was substituted with Ser, the mutated MPB83 associated with the aqueous phase. The cloned gene was used to determine the distribution of mpb83 in various Mycobacterium species. The gene was present in the M. tuberculosis (Mt) complex organisms, as well as in M. kansasii. In addition, Southern blot analysis of Mb and Mt DNA indicated that the mpb83 and mpb70 genes are located close to each other on the genome. Western blot analysis of cell lysates of various Mycobacterium species indicated that only Mt H37Rv and H37Ra produced proteins which reacted with mAb3C4. Furthermore, only two out of six of the Mb field isolates produced detectable antigen, indicating that expression of the mpb83 gene is variable within the Mt complex organisms.


Subject(s)
Bacterial Proteins/chemistry , Deoxyribonuclease I/genetics , Lipoproteins/chemistry , Mycobacterium bovis/chemistry , Antibodies, Monoclonal , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Cloning, Molecular , DNA, Bacterial , Gene Expression , Lipoproteins/genetics , Lipoproteins/metabolism , Molecular Sequence Data , Mutation , Mycobacterium bovis/genetics , Mycobacterium bovis/metabolism
20.
J Med Microbiol ; 43(3): 189-91, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7650726

ABSTRACT

Biopsy samples from a heart transplant patient with cellulitis and bursitis yielded an isolate of Mycobacterium haemophilum. The isolate was identified on the basis of a growth requirement for haemin or ferric ammonium citrate, growth at 30 degrees C but not at 37 degrees C, negative catalase test, intracellular growth in McCoy fibroblasts and sequence identify with a portion of the 16S rRNA sequence of the type strain. In comparisons with known 16S rRNA sequences, M. haemophilum grouped with other pathogenic, slow-growing mycobacteria, showing close sequence similarity to M. marinum (98.8%) and lower similarity to M. ulcerans and M. tuberculosis complex organisms. M. haemophilum and M. marium share other features including optimal growth at 30 degrees C and the ability to cause superficial skin lesions in man.


Subject(s)
Bursitis/microbiology , Cellulitis/microbiology , Heart Transplantation , Mycobacterium Infections/microbiology , Mycobacterium haemophilum/genetics , RNA, Ribosomal, 16S/genetics , Base Sequence , Cloning, Molecular , DNA, Bacterial/chemistry , Humans , Male , Middle Aged , Molecular Sequence Data , Mycobacterium haemophilum/classification , Mycobacterium haemophilum/isolation & purification , Nontuberculous Mycobacteria/classification , Nontuberculous Mycobacteria/genetics , Polymerase Chain Reaction , RNA, Ribosomal, 16S/chemistry , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...